RxDoctor Payments Data

Dena Truett, APRN

Nurse Practitioner · East Bernstadt, KYNPI 1184965766

Payments from drug & device makers

$857in general payments, 2019–2025

Across 50 payments — averaging $17.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$169
  • Novo Nordisk$137
  • Abbott$69
  • Boehringer Ingelheim$62
  • Pfizer$46
  • Ultragenyx Pharmaceutical Inc.$44
  • plus $329 from 15 others

What the payments were for

  • Food & beverage$857100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$857 in reported general payments places this provider in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,035
Medicare patients
51
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban36$30,038
MounjaroTirzepatide19$19,788
OzempicSemaglutide15$15,758
JardianceEmpagliflozin15$13,481
JanuviaSitagliptin Phosphate14$11,844
LinzessLinaclotide20$11,526
FarxigaDapagliflozin Propanediol15$10,891
Breo ElliptaFluticasone/Vilanterol13$4,974
Humalog Kwikpen U-100Insulin Lispro14$3,772
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$2,459
Albuterol Sulfate HfaAlbuterol Sulfate62$1,377
Ventolin HfaAlbuterol Sulfate20$1,071
Levothyroxine Sodium99$892
Gabapentin88$603
Doxycycline Hyclate81$600

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$46$30,03836 claims
Lilly USA, LLCMounjaro$32$19,78819 claims
Novo NordiskOzempic$137$15,75815 claims
Boehringer IngelheimJardiance$62$13,48115 claims
AbbVieLinzess$20$11,52620 claims
AstraZenecaFarxiga$169$10,89115 claims
GSKBreo Ellipta$36$4,97413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in East Bernstadt

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →